Analystreport

Corcept Therapeutics Incorporated (NASDAQ: CORT) was given a new $17.00 price target on by analysts at Cantor Fitzgerald. They now have a "hold" rating on the stock.

Corcept Therapeutics Incorporated  (CORT) 
Last corcept therapeutics incorporated earnings: 2/20 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: corcept.com/investors